What is Unmind?
Headquartered in London, Unmind operates a comprehensive B2B mental health platform designed to empower organizations with clinically-validated tools, training, and data-driven insights. The company addresses the systemic challenges of workplace stress and burnout by providing a holistic digital ecosystem that supports employee mental health at scale. By bridging the gap between clinical expertise and corporate accessibility, Unmind enables enterprises to foster healthier, more resilient workforces through evidence-based interventions.
The platform's market position is defined by its commitment to scientific rigor and user-centric design, distinguishing it from generic wellness applications. As organizations increasingly recognize the correlation between mental health and operational performance, Unmind has emerged as a preferred partner for multinational corporations seeking to implement sustainable, long-term wellbeing strategies.
How much funding has Unmind raised?
Unmind has raised a total of $95.7M across 4 funding rounds:
Angel/Seed
$3.7M
Series A
$10M
Series B
$47M
Other Financing Round
$35M
Angel/Seed (2019): $3.7M with participation from Felix Capital, Michael Whitfield, and Chris Bruce
Series A (2020): $10M led by Project A Ventures and Felix Capital
Series B (2021): $47M supported by Felix Capital, True Capital, and EQT
Other Financing Round (2025): $35M featuring TELUS
Key Investors in Unmind
Felix Capital
A venture capital firm focused on the intersection of technology and creativity, supporting entrepreneurs who build brands that enhance the human experience.
EQT
A global private-capital investment platform that applies a thematic, sector-focused approach to technology and healthcare, supporting companies across various development stages.
Project A Ventures
A leading European early-stage tech investor that combines capital with a dedicated platform team of functional experts to support founders in scaling their businesses.
What's next for Unmind?
With the successful closure of this major strategic investment, Unmind is well-positioned to accelerate its product roadmap and expand its international footprint. The company is expected to leverage this capital to deepen its clinical research capabilities and enhance its data analytics suite, providing enterprise clients with more granular insights into organizational health trends. Furthermore, the infusion of resources will likely support the scaling of its sales and customer success teams to meet the rising demand for enterprise-grade mental health solutions across diverse global markets.
Looking ahead, Unmind remains focused on maintaining its leadership in the healthtech sector by continuously innovating its delivery models. The strategic alignment with its investor base provides not only the necessary financial runway but also the operational expertise required to navigate the complexities of the global digital health market, ensuring that Unmind remains at the forefront of the evolving workplace wellbeing paradigm.
